Registro:

Referencias:

• Tamanini, C., De Ambrogi, M., Angiogenesis in developing follicle and corpus luteum (2004) Reproduction in Domestic Animals, 39 (4), pp. 206-216. , DOI 10.1111/j.1439-0531.2004.00505.x
• Redmer, D.A., Reynolds, L.P., Angiogenesis in the ovary (1996) Reviews of Reproduction, 1 (3), pp. 182-192
• Zeleznik, A.J., Schuler, H.M., Reichert Jr., L.E., Gonadotropin-binding sites in the rhesus monkey ovary: Role of the vasculature in the selective distribution of human chorionic gonadotropin to the preovulatory follicle (1981) Endocrinology, 109 (2), pp. 356-362
• Zimmermann, R.C., Hartman, T., Kavic, S., Pauli, S.A., Bohlen, P., Sauer, M.V., Kitajewski, J., Vascular endothelial growth factor receptor 2-mediated angiogenesis is essential for gonadotropin-dependent follicle development (2003) Journal of Clinical Investigation, 112 (5), pp. 659-669. , DOI 10.1172/JCI200318740
• Maisonpierre, P.C., Suri, C., Jones, P.F., Bartunkova, S., Wiegand, S.J., Radziejewski, C., Compton, D., Yancopoulos, G.D., Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis (1997) Science, 277 (5322), pp. 55-60. , DOI 10.1126/science.277.5322.55
• Suri, C., Jones, P.F., Patan, S., Bartunkova, S., Maisonpierre, P.C., Davis, S., Sato, T.N., Yancopoulos, G.D., Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis (1996) Cell, 87 (7), pp. 1171-1180. , DOI 10.1016/S0092-8674(00)81813-9
• Kanda, S., Mochizuki, Y., Suematsu, T., Miyata, Y., Nomata, K., Kanetake, H., Sonic hedgehog induces capillary morphogenesis by endothelial cells through phosphoinositide 3-kinase (2003) Journal of Biological Chemistry, 278 (10), pp. 8244-8249. , DOI 10.1074/jbc.M210635200
• Abdel-Malak, N.A., Srikant, C.B., Kristof, A.S., Magder, S.A., Di Battista, J.A., Hussain, S.N., Angiopoietin-1 promotes endothelial cell proliferation and migration through AP-1-dependent autocrine production of interleukin-8 (2008) Blood, 111, pp. 4145-4154
• Cascone, I., Audero, E., Giraudo, E., Napione, L., Maniero, F., Philips, M.R., Collard, J.G., Bussolino, F., Tie-2-dependent activation of RhoA and Rac1 participates in endothelial cell motility triggered by angiopoietin-1 (2003) Blood, 102 (7), pp. 2482-2490. , DOI 10.1182/blood-2003-03-0670
• Goede, V., Schmidt, T., Kimmina, S., Kozian, D., Augustin, H.G., Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis (1998) Laboratory Investigation, 78 (11), pp. 1385-1394
• Hazzard, T.M., Molskness, T.A., Chaffin, C.L., Stouffer, R.L., Vascular endothelial growth factor (VEGF) and angiopoietin regulation by gonadotrophin and steroids in macaque granulosa cells during the peri-ovulatory interval (1999) Mol Hum Reprod, 5, pp. 1115-1121
• Abramovich, D., Rodriguez Celin, A., Hernandez, F., Tesone, M., Parborell, F., Spatiotemporal analysis of the protein expression of angiogenic factors and their related receptors during folliculogenesis in rats with and without hormonal treatment (2009) Reproduction, 137, pp. 309-320
• Parborell, F., Abramovich, D., Tesone, M., Intrabursal administration of the antiangiopoietin 1 antibody produces a delay in rat follicular development associated with an increase in ovarian apoptosis mediated by changes in the expression of BCL2 related genes (2008) Biology of Reproduction, 78 (3), pp. 506-513. , http://www.biolreprod.org/cgi/reprint/78/3/506?ck=nck, DOI 10.1095/biolreprod.107.063610
• Carmeliet, P., Angiogenesis in health and disease (2003) Nature Medicine, 9 (6), pp. 653-660. , DOI 10.1038/nm0603-653
• Azziz, R., Woods, K.S., Reyna, R., Key, T.J., Knochenhauer, E.S., Yildiz, B.O., The prevalence and features of the polycystic ovary syndrome in an unselected population (2004) Journal of Clinical Endocrinology and Metabolism, 89 (6), pp. 2745-2749. , DOI 10.1210/jc.2003-032046
• Franks, S., Polycystic ovary syndrome (1995) N Engl J Med, 333, pp. 853-861
• Dunaif, A., Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis (1997) Endocrine Reviews, 18 (6), pp. 774-800. , DOI 10.1210/er.18.6.774
• Amin, A.F., Abd El-Aal, D.E., Darwish, A.M., Meki, A.R., Evaluation of the impact of laparoscopic ovarian drilling on Doppler indices of ovarian stromal blood flow, serum vascular endothelial growth factor, and insulin-like growth factor-1 inwomenwith polycystic ovary syndrome (2003) Fertil Steril, 79, pp. 938-941
• Walters, K.A., Allan, C.M., Handelsman, D.J., Rodent models for human polycystic ovary syndrome (2012) Biol Reprod, , 15 February 10.1095/biolreprod.111.097808
• Anderson, E., Lee, G.Y., O'Brien, K., Polycystic ovarian condition in the dehydroepiandrosterone-treated rat model: Hyperandrogenism and the resumption of meiosis are major initial events associated with cystogenesis of antral follicles (1997) Anatomical Record, 249 (1), pp. 44-53. , DOI 10.1002/(SICI)1097-0185(199709)249:1<44::AID-AR6>3.0.CO;2-F
• Henmi, H., Endo, T., Nagasawa, K., Hayashi, T., Chida, M., Akutagawa, N., Iwasaki, M., Kudo, R., Lysyl oxidase and MMP-2 expression in dehydroepiandrosterone-induced polycystic ovary in rats (2001) Biology of Reproduction, 64 (1), pp. 157-162
• Honnma, H., Endo, T., Henmi, H., Nagasawa, K., Baba, T., Yamazaki, K., Kitajima, Y., Saito, T., Altered expression of Fas/Fas ligand/caspase 8 and membrane type 1-matrix metalloproteinase in atretic follicles within dehydroepiandrosterone-induced polycystic ovaries in rats (2006) Apoptosis, 11 (9), pp. 1525-1533. , DOI 10.1007/s10495-006-9148-2
• Solano, M.E., Elia, E., Luchetti, C.G., Sander, V., Di, G.G., Gonzalez, C., Motta, A.B., Metformin prevents embryonic resorption induced by hyperandrogenisation with dehydroepiandrosterone in mice (2006) Reproduction, Fertility and Development, 18 (5), pp. 533-544. , DOI 10.1071/RD05099
• Bas, D., Abramovich, D., Hernandez, F., Tesone, M., Altered expression of Bcl-2 and Bax in follicles within dehydroepiandrosterone-induced polycystic ovaries in rats (2011) Cell Biol Int, 35, pp. 423-429
• Solano, M.E., Sander, V.A., Ho, H., Motta, A.B., Arck, P.C., Systemic inflammation, cellular influx and up-regulation of ovarian VCAM-1 expression in a mouse model of polycystic ovary syndrome (PCOS) (2011) J Reprod Immunol, 92, pp. 33-44
• Kamat, B.R., Brown, L.F., Manseau, E.J., Senger, D.R., Dvorak, H.F., Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development (1995) Am J Pathol, 146, pp. 157-165
• Stanek, M.B., Borman, S.M., Molskness, T.A., Larson, J.M., Stouffer, R.L., Patton, P.E., Insulin and insulin-like growth factor stimulation of vascular endothelial growth factor production by luteinized granulosa cells: Comparison between Polycystic Ovarian Syndrome (PCOS) and non-PCOS women (2007) Journal of Clinical Endocrinology and Metabolism, 92 (7), pp. 2726-2733. , http://jcem.endojournals.org/cgi/reprint/92/7/2726, DOI 10.1210/jc.2006-2846
• Agrawal, R., Sladkevicius, P., Engmann, L., Conway, G.S., Payne, N.N., Bekis, J., Tan, S.-L., Jacobs, H.S., Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries (1998) Human Reproduction, 13 (3), pp. 651-655. , DOI 10.1093/humrep/13.3.651
• Abd El Aal, D.E., Mohamed, S.A., Amine, A.F., Meki, A.R., Vascular endothelial growth factor and insulin-like growth factor-1 in polycystic ovary syndrome and their relation to ovarian blood flow (2005) Eur J Obstet Gynecol Reprod Biol, 118, pp. 219-224
• Artini, P.G., Monti, M., Matteucci, C., Valentino, V., Cristello, F., Genazzani, A.R., Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation (2006) Gynecological Endocrinology, 22 (8), pp. 465-470. , DOI 10.1080/09513590600906607, PII P745G03892141374
• Zaidi, J., Campbell, S., Pittrof, R., Kyei-Mensah, A., Shaker, A., Jacobs, H.S., Tan, S.L., Ovarian stromal blood flow in women with polycystic ovaries - A possible new marker for diagnosis? (1995) Hum Reprod, 10, pp. 1992-1996
• Pellicer, A., Albert, C., Mercader, A., Bonilla-Musoles, F., Remohi, J., Simon, C., The pathogenesis of ovarian hyperstimulation syndrome: In vivo studies investigating the role of interleukin-1β interleukin-6, and vascular endothelial growth factor (1999) Fertility and Sterility, 71 (3), pp. 482-489. , DOI 10.1016/S0015-0282(98)00484-1, PII S0015028298004841
• Abramovich, D., Parborell, F., Tesone, M., Effect of a vascular endothelial growth factor (VEGF) inhibitory treatment on the folliculogenesis and ovarian apoptosis in gonadotropin-treated prepubertal rats (2006) Biology of Reproduction, 75 (3), pp. 434-441. , DOI 10.1095/biolreprod.106.051052
• Woodruff, T.K., Lyon, R.J., Hansen, S.E., Rice, G.C., Mather, J.P., Inhibin and activin locally regulate rat ovarian folliculogenesis (1990) Endocrinology, 127, pp. 3196-3205
• Andreu, C., Parborell, F., Vanzulli, S., Chemes, H., Tesone, M., Regulation of follicular luteinization by a gonadotropin-releasing hormone agonist: Relationship between steroidogenesis and apoptosis (1998) Molecular Reproduction and Development, 51 (3), pp. 287-294. , DOI 10.1002/(SICI)1098-2795(199811)51:3<287::AID-MRD8>3.0.CO;2-L
• Sadrkhanloo, R., Hofeditz, C., Erickson, G.F., Evidence for widespread atresia in the hypophysectomized estrogen-treated rat (1987) Endocrinology, 120 (1), pp. 146-155
• Convery, M., McCarthy, G.F., Brawer, J.R., Remission of the polycystic ovarian condition (PCO) in the rat following hemiovariectomy (1990) Anatomical Record, 226 (3), pp. 328-336
• Lara, H.E., Dissen, G.A., Leyton, V., Paredes, A., Fuenzalida, H., Fiedler, J.L., Ojeda, S.R., An increased intraovarian synthesis of nerve growth factor and its low affinity receptor is a principal component of steroid-induced polycystic ovary in the rat (2000) Endocrinology, 141 (3), pp. 1059-1072. , DOI 10.1210/en.141.3.1059
• Rasband, W.S., (2007) Image J, , http://rsb.info.nih.gov/ij/, Bethesda, MD: 1997
• Irusta, G., Parborell, F., Peluffo, M., Manna, P.R., Gonzalez-Calvar, S.I., Calandra, R., Stocco, D.M., Tesone, M., Steroidogenic acute regulatory protein in ovarian follicles of gonadotropin-stimulated rats is regulated by a gonadotropin-releasing hormone agonist (2003) Biology of Reproduction, 68 (5), pp. 1577-1583. , DOI 10.1095/biolreprod.102.009944
• Yamagishi, S.-I., Yonekura, H., Yamamoto, Y., Fujimori, H., Sakurai, S., Tanaka, N., Yamamoto, H., Vascular endothelial growth factor acts as a pericyte mitogen under hypoxic conditions (1999) Laboratory Investigation, 79 (4), pp. 501-509
• Ribatti, D., Nico, B., Crivellato, E., The role of pericytes in angiogenesis (2011) Int J Dev Biol, 55, pp. 261-268
• Brannian, J.D., Eyster, K.M., Weber, M., Diggins, M., Pioglitazone administration alters ovarian gene expression in aging obese lethal yellow mice (2008) Reprod Biol Endocrinol, 6, p. 10
• Artini, P.G., Ruggiero, M., Parisen Toldin, M.R., Monteleone, P., Monti, M., Cela, V., Genazzani, A.R., Vascular endothelial growth factor and its soluble receptor in patients with polycystic ovary syndrome undergoing IVF (2009) Hum Fertil (Camb), 12, pp. 40-44
• Savchev, S.I., Moragianni, V.A., Senger, D., Penzias, A.S., Thornton, K., Usheva, A., Follicular fluid-specific distribution of vascular endothelial growth factor isoforms and sFlt-1 in patients undergoing IVF and their correlation with treatment outcomes (2010) Reprod Sci, 17, pp. 1036-1042
• Gómez, R., Ferrero, H., Delgado-Rosas, F., Gaytan, M., Morales, C., Zimmermann, R.C., Simón, C., Pellicer, A., Evidences for the existence of a low dopaminergic tone in polycystic ovarian syndrome: Implications for OHSS development and treatment (2011) J Clin Endocrinol Metab, 96, pp. 2484-2492
• Lee, M.T., Anderson, E., Lee, G.Y., Changes in ovarian morphology and serum hormones in the rat after treatment with dehydroepiandrosterone (1991) Anat Rec, 231, pp. 185-192
• Sander, V., Luchetti, C.G., Solano, M.E., Elia, E., Di Girolamo, G., Gonzalez, C., Motta, A.B., Role of the N,N′-dimethylbiguanide metformin in the treatment of female prepubertal BALB/c mice hyperandrogenized with dehydroepiandrosterone (2006) Reproduction, 131, pp. 591-602
• Luchetti, C.G., Solano, M.E., Sander, V., Arcos, M.L.B., Gonzalez, C., Di, G.G., Chiocchio, S., Motta, A.B., Effects of dehydroepiandrosterone on ovarian cystogenesis and immune function (2004) Journal of Reproductive Immunology, 64 (1-2), pp. 59-74. , DOI 10.1016/j.jri.2004.04.002, PII S0165037804000695
• Familiari, G., Toscano, V., Motta, P.M., Morphological studies of polycystic mouse ovaries induced by dehydroepiandrosterone (1985) Cell and Tissue Research, 240 (3), pp. 519-528. , DOI 10.1007/BF00216340
• Webber, L.J., Stubbs, S., Stark, J., Trew, G.H., Margara, R., Hardy, K., Franks, S., Formation and early development of follicles in the polycystic ovary (2003) Lancet, 362 (9389), pp. 1017-1021. , DOI 10.1016/S0140-6736(03)14410-8
• Franks, S., Stark, J., Hardy, K., Follicle dynamics and anovulation in polycystic ovary syndrome (2008) Human Reproduction Update, 14 (4), pp. 367-378. , DOI 10.1093/humupd/dmn015
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) (2004) Hum Reprod, 19, pp. 41-47. , Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
• Chang, R.J., The reproductive phenotype in polycystic ovary syndrome (2007) Nature Clinical Practice Endocrinology and Metabolism, 3 (10), pp. 688-695. , DOI 10.1038/ncpendmet0637, PII NCPENDMET0637
• Franks, S., Hardy, K., Aberrant follicle development and anovulation in polycystic ovary syndrome (2010) Ann Endocrinol, 71, pp. 228-230. , Paris
• Albiges, L., Salem, M., Rini, B., Escudier, B., Vascular endothelial growth factor-targeted therapies in advanced renal cell carcinoma (2011) Hematol Oncol Clin North Am, 25, pp. 813-833
• Leite De Oliveira, R., Hamm, A., Mazzone, M., Growing tumor vessels: More than one way to skin a cat-implications for angiogenesis targeted cancer therapies (2011) Mol Aspects Med, 32, pp. 71-87
• Sharma, P.S., Sharma, R., Tyagi, T., VEGF/VEGFR pathway inhibitors as anti-angiogenic agents: Present and future (2011) Curr Cancer Drug Targets, 11, pp. 624-653
• Socinski, M.A., Multitargeted receptor tyrosine kinase inhibition: An antiangiogenic strategy in non-small cell lung cancer (2011) Cancer Treat Rev, 37, pp. 611-617
• Ribeiro, J.A., Messias, A., Jorge, R., Antiangiogenic drugs and advanced proliferative diabetic retinopathy (2011) Arq Bras Oftalmol, 74, pp. 143-146
• Bauditz, J., Lochs, H., Angiogenesis and vascular malformations: Antiangiogenic drugs for treatment of gastrointestinal bleeding (2007) World Journal of Gastroenterology, 13 (45), pp. 5979-5984. , DOI 10.3748/wjg.13.5979
• Mitchell, P., A systematic review of the efficacy and safety outcomes of anti-VEGF agents used for treating neovascular age-related macular degeneration: Comparison of ranibizumab and bevacizumab (2011) Curr Med Res Opin, 27, pp. 1465-1475
• Ball, S.G., Shuttleworth, C.A., Kielty, C.M., Vascular endothelial growth factor can signal through platelet-derived growth factor receptors (2007) Journal of Cell Biology, 177 (3), pp. 489-500. , http://www.jcb.org/cgi/reprint/177/3/489.pdf, DOI 10.1083/jcb.200608093
• Hellstrom, M., Gerhardt, H., Kalen, M., Li, X., Eriksson, U., Wolburg, H., Betsholtz, C., Lack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesis (2001) Journal of Cell Biology, 152 (3), pp. 543-553
• Armulik, A., Abramsson, A., Betsholtz, C., Endothelial/pericyte interactions (2005) Circulation Research, 97 (6), pp. 512-523. , DOI 10.1161/01.RES.0000182903.16652.d7
• Hoch, R.V., Soriano, P., Roles of PDGF in animal development (2003) Development, 130 (20), pp. 4769-4784. , DOI 10.1242/dev.00721

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------